Reid G. Adler - 02 May 2022 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
CHIEF LEGAL OFFICER
Signature
/s/ Jerrold D. Doston, Attorney-in-Fact
Issuer symbol
VTGN
Transactions as of
02 May 2022
Net transactions value
$0
Form type
4
Filing time
03 May 2022, 17:10:46 UTC
Next filing
19 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTGN Stock Options (right to buy) Award $0 +200,000 $0.000000 200,000 02 May 2022 Common Stock 200,000 $1.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the stock options vest on May 2, 2023 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date.